Records containing: Ovarian Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-05-25An Open-label, Randomized, Multicenter Phase III Clinical Trial of SHR - A1811 Versus Investigator's Choice of Chemotherapy in the Treatment of Platinum-resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer With HER2 Expression
-
CLINICAL_TRIALS study record update · 2025-05-25An Open-label, Multi-center Phase Ib/II Clinical Study of the Combination Regimen of SHR - A1811 Injection in the Treatment of Platinum-sensitive Recurrent Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2025-05-23A Phase 1-2 Study of the Combination of Olaparib and Tremelimumab, in BRCA1 and BRCA2 Mutation Carriers With Recurrent Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2025-05-23Safety, Pharmacokinetics (PK), and Efficacy of ONC-392 as a Single Agent and in Combination With Pembrolizumab in Advanced Solid Tumors and NSCLC: An Open Label Phase IA/IB Study. Preserve CTLA4 Checkpoint Function (PRESERVE-001)
-
CLINICAL_TRIALS study record update · 2025-05-23Phase II Investigational Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-05-22Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2025-05-22Open Label Pilot Study Evaluating Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-05-22A Phase 1 Study of The Safety and Tolerability of COM902 in Subjects With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2025-05-22A Randomized Placebo-controlled Evaluation of GTPase Inhibition by Post-operative Intravenous Ketorolac in Ovarian Cancer Patients
-
CLINICAL_TRIALS study record update · 2025-05-22Single Institution (UNM) Prospective Laboratory Study of Cancer and Immune Cells in the Ascites Fluid of Ovarian Cancer Patients to Test Alternative Therapies
-
CLINICAL_TRIALS study record update · 2025-05-21Open Label, Phase 1a, Dose-Escalation Study Evaluating the Safety of Fractionated MNPR-101-PCTA-177Lu Dosing in the Treatment of Solid Tumor Cancers
-
CLINICAL_TRIALS study record update · 2025-05-18Identification of Ovarian Malignancy With Ultrasonography Based Criteria (IOTA) and Serum CA 125
-
CLINICAL_TRIALS study record update · 2025-05-18Perioperative Stress Reduction in Ovarian Cancer (PRESERVE Trial)-A Prospective Randomized Pilot Study
-
CLINICAL_TRIALS study record update · 2025-05-16EON: A Single-arm Phase II Study of Etigilimab (OMP-313M32) in Combination With Checkpoint Inhibition (Nivolumab) in Patients With Platinum-resistant, Recurrent Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2025-05-16Transforming Ovarian Cancer Diagnostic Pathways (TranSforming Ovarian caNcer diAgnosTic pAthways: A Hybrid Type 1 Effectiveness-implementation Study of a Novel Biomarker Based, Threshold Driven Pathway for Earlier Ovarian Cancer Diagnosis
-
CLINICAL_TRIALS study record update · 2025-05-15RXDX-105 for the Treatment of Patients With Non-Small Cell Lung Cancer (NSCLC) Harboring a RET Gene Fusion and a Patient With Ovarian Cancer Harboring a BRAF Gene Mutation
-
CLINICAL_TRIALS study record update · 2025-05-15A Phase I/II Trial Investigating the Tolerability, Toxicity and Efficacy of Tamoxifen and SUBA-Itraconazole in Patients With Platinum Resistant Recurrent Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2025-05-13Prospective, International, Randomized, Multicentric, Controlled Study on the Performance of SYMMCORA® Mid-term Unidirectional Barbed Suture Versus V-loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy
-
CLINICAL_TRIALS study record update · 2025-05-06Tempus Priority Study: An Observational Study of Patients Who Have Received Comprehensive Genomic Profiling
-
CLINICAL_TRIALS study record update · 2025-05-06Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
-
CLINICAL_TRIALS study record update · 2025-05-04A Phase 1/1b Clinical Trial of Niraparib and Neratinib in Advanced Solid Tumors With an Expansion Cohort in Platinum-resistant Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2025-05-02A Phase 1b/2a Three-Part Open-Label Multicenter Study to Evaluate the Safety and Efficacy of LY2880070 as Monotherapy and in Combination With Gemcitabine in Patients With Advanced or Metastatic Cancer
-
CLINICAL_TRIALS study record update · 2025-05-01A Phase I/II, Open Label, Multi-center, Non-randomized Dose Escalation and Dose Expansion Study of AMXI-5001 in Patients With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2025-04-29A Pilot Study of Prehabilitation During the Neoadjuvant Window of Opportunity in Older Women With Ovarian Cancer (FIT4SURGERY)
-
CLINICAL_TRIALS study record update · 2025-04-29Phase I Study of Human Chimeric Antigen Receptor Modified T Cells in Patients With Mesothelin Expressing Cancers